Now showing items 1-1 of 1
Comparative study on liposomal amphotericin B and other therapies in the treatment of mucosal leishmaniasis: A 15-year retrospective cohort study
(PLoS One. 2019 Jun 26;14(6):e0218786. doi: 10.1371/journal.pone.0218786., 2019-06)
BACKGROUND: Liposomal amphotericin B (L-AMB) has been used for mucosal leishmaniasis (ML), but comparative studies on L-AMB and other drugs used for the treatment of ML have not been conducted. The present study aimed to ...